Oracle (NYSE:ORCL) Trading Down 2.8% - Should You Sell?

Key Points

• Oracle's stock price decreased by 2.8% during mid-day trading, reaching a low of $283.00, with a significant trading volume increase to 25,833,821 shares.
• Analysts have varied opinions on Oracle, with price targets ranging from $135.00 to $360.00, and an average consensus price target of $304.71, indicating a Moderate Buy rating overall.
• Oracle announced a quarterly dividend of $0.50 per share, with a yield of 0.7%, and has set its Q2 2026 earnings guidance to $1.270-1.310 EPS.

Oracle Corporation (NYSE:ORCL - Get Free Report)'s stock price fell 2.8% during mid-day trading on Friday . The stock traded as low as $283.00 and last traded at $283.29. 25,833,821 shares changed hands during trading, an increase of 77% from the average session volume of 14,589,353 shares. The stock had previously closed at $291.33.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. DA Davidson upped their price target on Oracle from $220.00 to $300.00 and gave the stock a "neutral" rating in a report on Wednesday, September 10th. Loop Capital set a $135.00 target price on shares of Oracle in a research note on Tuesday, June 10th. Redburn Partners set a $175.00 price target on shares of Oracle in a research report on Thursday. JPMorgan Chase & Co. boosted their price target on shares of Oracle from $185.00 to $210.00 and gave the stock a "neutral" rating in a report on Monday, September 8th. Finally, Jefferies Financial Group increased their price objective on shares of Oracle from $270.00 to $360.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Oracle presently has an average rating of "Moderate Buy" and a consensus price target of $304.71.

Oracle Stock Performance

The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The company has a 50 day simple moving average of $257.43 and a 200-day simple moving average of $199.48. The stock has a market capitalization of $805.03 billion, a P/E ratio of 65.58, a price-to-earnings-growth ratio of 3.33 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter in the previous year, the company posted $1.39 EPS. The firm's revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities analysts forecast that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle's dividend payout ratio (DPR) is 46.30%.

Insider Buying and Selling at Oracle

In related news, Director Rona Alison Fairhead bought 480 shares of the company's stock in a transaction on Monday, July 7th. The shares were purchased at an average price of $233.87 per share, for a total transaction of $112,257.60. Following the completion of the transaction, the director directly owned 22,110 shares in the company, valued at approximately $5,170,865.70. The trade was a 2.22% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Clayton M. Magouyrk sold 21,241 shares of Oracle stock in a transaction on Friday, September 12th. The shares were sold at an average price of $297.11, for a total value of $6,310,913.51. Following the completion of the transaction, the insider owned 78,000 shares of the company's stock, valued at approximately $23,174,580. This trade represents a 21.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 112,092 shares of company stock worth $32,960,165. Company insiders own 42.20% of the company's stock.

Hedge Funds Weigh In On Oracle

A number of large investors have recently modified their holdings of ORCL. Norges Bank bought a new position in Oracle in the 2nd quarter valued at $4,275,378,000. Nuveen LLC bought a new stake in Oracle during the first quarter valued at $732,692,000. GAMMA Investing LLC grew its position in Oracle by 15,012.3% during the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock worth $664,810,000 after buying an additional 4,723,631 shares in the last quarter. Vanguard Group Inc. grew its position in Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock worth $22,498,982,000 after buying an additional 3,513,464 shares in the last quarter. Finally, Kingstone Capital Partners Texas LLC bought a new position in Oracle in the 2nd quarter worth about $731,512,000. 42.44% of the stock is currently owned by institutional investors.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.